Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
BAYN.SWDay performance
| BAYN.SW | |
|---|---|
| Price | 67.99 |
| Change Pct | 0.00 |
| Change Abs | 0.00 |
| Market Cap | 66.8 billion |
| Eps | 4.74 |
| Pe Ratio | 14.34 |
| Outstanding Shares | 982.4 million |
| Volume | 0 |
| Avg Volume | 18373 |
| Industry | Drug Manufacturers—General |
| Sector Name | Health Care |
| Country Short Name | DE |
| Announcement Earnings | 2023-03-31 04:00:00+00:00 |
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
The peer analysis is for none of your tickers available
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
BAYN.SW
Company descriptions
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology;